Clinical trial

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

NCT00976508

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-11-01

PhasePHASE1

Study timeline

Study start (unknown)2009-11-01Date precision: month

Registry last updated2013-12-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Colorectal Neoplasmsunresolved

Lung Neoplasmsunresolved

Breast Neoplasmsunresolved

Prostatic Neoplasmsunresolved

Sarcomaunresolved

Interventions

figitumumabDRUG

pegvisomantDRUG · verified · RxNorm: pegvisomant

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

MontrealQuebec, Canada1 MinneapolisMinnesota, United States1 RochesterMinnesota, United States1 HelsinkiFinland1 MünsterGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00976508 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.